|
|
| | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Basic information |
| Product Name: | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 | | Synonyms: | naphthalen-1-yl-[2,4,5,6,7-pentadeuterio-1-(3-hydroxybutyl)indol-3-yl]methanone;(±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5;[2H5]-JWH073-3-Hydroxybutyl metabolite;(±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 | | CAS: | 1413427-47-0 | | MF: | C23H16D5NO2 | | MW: | 348.44914889 | | EINECS: | | | Product Categories: | | | Mol File: | 1413427-47-0.mol |  |
| | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Chemical Properties |
| solubility | DMF: 30 mg/ml; DMF:PBS (pH 7.2) (1:9): 0.1 mg/ml; DMSO: 30 mg/ml; Ethanol: 0.5 mg/ml |
| | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Usage And Synthesis |
| Description | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 is intended for use as an internal standard for the quantification of (±)-JWH 073 N-(3-hydroxybutyl) metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a potent cannabimimetic that has been identified as an adulterant in smoking mixtures. JWH 073 N-(3-hydroxybutyl) metabolite is expected to be produced by hepatic metabolism of JWH 073.1,2 The biological actions of this metabolite are unknown. | | Uses | JWH-073 (Indole-d5) 3-Hydroxybutyl is labelled JWH-073 3-Hydroxybutyl (J211435), a urinary metabolite of JWH-073 (B693550) which acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. | | References | 1. Wintermeyer, A., Mller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398(5),2141-2153(2010).
2. Zhang, Q., Ma, P., Cole, R.B., et al. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS Anal. Bioanal. Chem. 386(5),1345-1355(2006). |
| | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Preparation Products And Raw materials |
|